Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Atuzaginstat

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cortexyme Announces Preclinical Data Showing Benefits of Atuzaginstat
    Cortexyme Announces Preclinical Data Showing Benefits of Atuzaginstat

    09 Mar 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220309005301/en

    BUSINESSWIRE
    09 Mar 2022
    Share Share
    Cortexyme to focus on 2nd Alzheimer's bet after clinical hold
    Cortexyme to focus on 2nd Alzheimer's bet after clinical hold

    27 Jan 2022

    // K. LaHucik FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/fda-slaps-hold-cortexyme-s-failed-alzheimer-s-drug-forcing-biotech-to-seek-alternatives-for

    K. LaHucik FIERCEBIOTECH
    27 Jan 2022
    Share Share
    Cortexyme picks a lower dose for nebulous Alzheimer's drug
    Cortexyme picks a lower dose for nebulous Alzheimer's drug

    13 Nov 2021

    // N. Pagliarulo BIOPHARMADIVE

    https://www.biopharmadive.com/news/cortexyme-alzheimers-detailed-study-data-ctad/609920/

    N. Pagliarulo BIOPHARMADIVE
    13 Nov 2021
    Share Share
    Cortexyme will forge ahead with failed Alzheimer's drug
    Cortexyme will forge ahead with failed Alzheimer's drug

    27 Oct 2021

    // D. Garde STATNEWS

    https://www.statnews.com/2021/10/26/cortexyme-bacteria-fighting-alzheimers-drug-fails-primary-goal/

    D. Garde STATNEWS
    27 Oct 2021
    Share Share
    Cortexyme Expands Pipeline with Initiation of Phase 1 Trial of COR588
    Cortexyme Expands Pipeline with Initiation of Phase 1 Trial of COR588

    08 Sep 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210908005279/en

    BUSINESSWIRE
    08 Sep 2021
    Share Share